MEGAN HEUSINKVELT: Open Payments
NPI 1003243783 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$734 in 35 payments from 8 companies in 2025. Trend: 2023 $880 · 2024 $731 · 2025 $734
Food & beverage: $635Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 11 | $306 |
| MAYNE PHARMA COMMERCIAL LLC | 13 | $206 |
| CooperSurgical, Inc. | 2 | $45 |
| Exeltis, USA Inc. | 2 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| Sumitomo Pharma America, Inc. | 2 | $38 |
| Biogen, Inc. | 2 | $36 |
| ABBVIE INC. | 1 | $23 |
Products named: Veozah, Paragard T 380A, SLYND, MYFEMBREE, ZURZUVAE, LILETTA, Lynkuet, Mirena.
Industry payments across NE — which companies pay providers there.
